Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues
- PMID: 26845116
- DOI: 10.1016/j.jtho.2015.10.005
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues
Abstract
Introduction: Fusions of the anaplastic lymphoma receptor tyrosine kinase gene (ALK), ret proto-oncogene (RET), ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1), B-Raf proto-oncogene, serine/threonine kinase gene (BRAF), and neuregulin 1 gene (NRG1) and intronic MMNG HOS Transforming gene (MET) mutations are druggable oncogene alterations in lung adenocarcinoma that cause expression of aberrant transcripts. Because these aberrant transcripts are both infrequent (incidence <5%) and mutually exclusive, multiplex assays are required to detect them in tumor samples.
Methods: Aberrant transcripts of the six aforementioned oncogenes (36 transcripts in total) were examined in a molecular counting (MC) assay, which counts RNA molecules by simultaneous hybridization of several probes. Forty-one samples of surgically resected lung adenocarcinoma tissue found to express one of these aberrant oncogenic transcripts upon whole transcriptome sequencing (test cohort: n = 22) or reverse transcription polymerase chain reaction (validation cohort: n = 19) analyses were subjected to MC, after which biopsies were performed on tumor tissue samples.
Results: Threshold values for the diagnosis of each of the 36 transcripts were determined in frozen and formalin-fixed paraffin-embedded samples from the test cohort. On the basis of these threshold values, the MC assay diagnosed expression of oncogenic transcripts in the validation cohort samples with 100% accuracy. The assay also accurately detected oncogenic fusions in bronchial lavage fluid and transbronchial biopsy samples.
Conclusions: The MC assay allows multiplex detection of oncogenic fusion and exon-skipped transcripts in tumor samples, including in formalin-fixed paraffin-embedded samples obtained in the clinic.
Keywords: Genetic diagnosis; MET exon skipping; Molecular counting; Oncogene fusion; Personalized medicine.
Copyright © 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.Virchows Arch. 2024 Apr;484(4):677-686. doi: 10.1007/s00428-024-03778-9. Epub 2024 Mar 16. Virchows Arch. 2024. PMID: 38492039 Free PMC article.
-
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.Clin Chem. 2017 Mar;63(3):751-760. doi: 10.1373/clinchem.2016.265314. Epub 2017 Jan 10. Clin Chem. 2017. PMID: 28073897
-
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.Cancer. 2017 May 15;123(10):1731-1740. doi: 10.1002/cncr.30539. Epub 2017 Feb 8. Cancer. 2017. PMID: 28177518
-
Emerging Biomarkers in Personalized Therapy of Lung Cancer.Adv Exp Med Biol. 2016;890:25-36. doi: 10.1007/978-3-319-24932-2_2. Adv Exp Med Biol. 2016. PMID: 26703797 Review.
-
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?Arch Pathol Lab Med. 2018 Apr;142(4):480-489. doi: 10.5858/arpa.2017-0135-RA. Epub 2018 Jan 26. Arch Pathol Lab Med. 2018. PMID: 29372843 Review.
Cited by
-
Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib.Clin Cancer Res. 2025 Jul 1;31(13):2675-2684. doi: 10.1158/1078-0432.CCR-24-4097. Clin Cancer Res. 2025. PMID: 40310449 Free PMC article. Clinical Trial.
-
ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.Cancers (Basel). 2017 Aug 12;9(8):107. doi: 10.3390/cancers9080107. Cancers (Basel). 2017. PMID: 28805682 Free PMC article. Review.
-
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.Jpn J Clin Oncol. 2021 Aug 1;51(8):1261-1268. doi: 10.1093/jjco/hyab072. Jpn J Clin Oncol. 2021. PMID: 34037224 Free PMC article.
-
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.BMC Cancer. 2016 Aug 5;16:603. doi: 10.1186/s12885-016-2646-x. BMC Cancer. 2016. PMID: 27495736 Free PMC article.
-
Molecular Testing on Cytology for Gene Fusion Detection.Front Med (Lausanne). 2021 Jul 6;8:643113. doi: 10.3389/fmed.2021.643113. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34295907 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous